Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Suspends Valneva’s Ixchiq Based On Four New Serious AE Reports
Aug 25 2025
•
By
Sue Sutter
Suspending a BLA is an unusual move for the US FDA.
(Shutterstock)
More from Anti-infective
More from R&D